Company: CGC
Filing Date: 2025-06-06
Form Type: 424B5
Source: 0001104659-25-057337
Chunk: 5

Company: Canopy Growth Corp
Filing Date: 2025-06-06
Form: 424B5
Chunk 5
---
 Shares are converted into Exchangeable Shares during the term of this offering); • up to 5,955,916 of our Common Shares issuable upon the exercise of stock options outstanding as of June 4, 2025 under the Canopy Growth Corporation Omnibus Equity Incentive Plan (the “Omnibus Incentive Plan”) at a weighted average exercise price of $13.83 (C$18.92 per Common Share);

S-3

TABLE OF CONTENTS

•

up to 4,575,364 Common Shares issuable upon the vesting of restricted share units outstanding under the Omnibus Incentive Plan;

•

up to 73,461 Common Shares issuable upon the vesting of performance share units outstanding under the Omnibus Incentive Plan;

•

up to 8,084,490 Common Shares available for future issuance under the Omnibus Incentive Plan, based on the Common Shares outstanding as of June 4, 2025 (the Omnibus Incentive Plan provides that the aggregate number of Common Shares reserved for issuance for awards granted under the Omnibus Incentive Plan and under all other equity plans of the Company shall not exceed 10% of the Company’s total issued and outstanding Common Shares from time to time);

•

up to 15,483,580 Common Shares issuable upon exercise of common share purchase warrants (“Warrants”) with a weighted average exercise price of $7.56 (C$10.47) per Common Share;

•

up to 8,239 Common Shares issuable upon the conversion of the convertible debentures due September 2025 issued by the Company’s wholly-owned subsidiary, The Supreme Cannabis Company, Inc.;

•

up to 6,700,860 Common Shares issuable upon the conversion of the Company’s convertible debentures due May 2029 with a conversion price of C$14.38 per Common Share; and

•

68,469 Common Shares issuable in connection with Canopy USA’s acquisition of the minority interests of certain subsidiaries of Acreage.

In addition, the number of Common Shares outstanding does not reflect other future issuances of Common Shares. See “Risk Factors — Risks Related to This Offering — Our shareholders may be subject to dilution resulting from future issuances of Common Shares by us.”

<div align='center'>S-4</div>

TABLE OF CONTENTS

### RISK FACTORS
Investing in our Common Shares involves a high degree of risk. Before deciding whether to invest in our